Sandbox29: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Student (talk | contribs)
No edit summary
Student (talk | contribs)
No edit summary
Line 10: Line 10:


{{STRUCTURE_1eve |  PDB=1eve  |  SCENE=  }}
{{STRUCTURE_1eve |  PDB=1eve  |  SCENE=  }}
Reference to the Proteopedia pages dedicated to 1EVE, contributors are Eran Hodis, Joel L. Sussman, OCA, Wayne Decatur

Revision as of 16:33, 4 March 2009

1EVE

This sandbox is in use until June 1, 2009 for UMass Chemistry 490a. Others please do not edit this page. Thanks!


Created by Lori Mathis

1eve is a protein that is a drug used to prevent Alzheimer disease. The overall structure of 1EVE contains a beta sheet section with 15 sheets and 16 alpha helices. 1eve is a fairly standard molecule in the sense that the hydrophic aspects of the protein are well-maintained on the inside, while the hydrophillic portions are around the outside. 1eve has an active name called Acetylcholinesterase, which has a ligand called Aricept. 1eve is considered an AChE inhibitor, in which it has a high affinity for. The overall protein itself was created by a Japanese corporation called the Eisai Company.


Drag the structure with the mouse to rotate
1eve, resolution 2.50Å (default scene)
Ligands: E20, NAG
Activity: Acetylcholinesterase, with EC number 3.1.1.7
Resources: FirstGlance, OCA, RCSB, PDBsum
Coordinates: save as pdb, mmCIF, xml



Reference to the Proteopedia pages dedicated to 1EVE, contributors are Eran Hodis, Joel L. Sussman, OCA, Wayne Decatur